Michèle Algarté-Génin

Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136

Christine Katlama, Marc Antoine Valantin, Michèle Algarté-Génin et al. · AIDS · 2010 · 164 citations

Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study

Jean‐Michel Molina, Jade Ghosn, Lambert Assoumou et al. · The Lancet HIV · 2022 · 134 citations

Sexual Health, Preventive Medicine, Treatment And Prevention +10

Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

Jean‐Michel Molina, Béatrice Berçot, Lambert Assoumou et al. · The Lancet Infectious Diseases · 2024 · 129 citations

Vaccination, Vaccine Safety, Preventive Medicine +9

Factors Associated With Virological Failure in HIV-1–Infected Patients Receiving Darunavir/Ritonavir Monotherapy

Sidonie Lambert-Niclot, Philippe Flandre, Marc‐Antoine Valantin et al. · The Journal of Infectious Diseases · 2011 · 82 citations · Full text

Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era

Caroline Besson, Rémi Lancar, Sophie Prévôt et al. · AIDS · 2017 · 79 citations